Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice
NCT01186133 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50000
Last updated 2025-06-13
Summary
The objective of this study is to evaluate effectiveness and safety of the new drug-eluting stent (DES), as compared with the first-,second-,third-, and fourth-generation DES, in the "real world" daily practice.
Conditions
- Coronary Artery Disease
- Percutaneous Transluminal Coronary Angioplasty
Sponsors & Collaborators
-
CardioVascular Research Foundation, Korea
collaborator OTHER -
Seung-Jung Park
lead OTHER
Principal Investigators
-
Seung-Jung Park, MD · Asan Medical Center
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-01-31
- Primary Completion
- 2030-12-31
- Completion
- 2030-12-31
Countries
- South Korea
More Related Trials
-
Evaluation of Effectiveness and Safety of NOBORI Stent
NCT01348360 ·Status: COMPLETED
-
Evaluation of Effectiveness and Safety of Synergy XD and Synergy Megatron™ Stent
NCT05044273 ·Status: RECRUITING
-
Diffuse Type In-Stent Restenosis After Drug-Eluting Stent
NCT00485030 ·Status: COMPLETED ·Phase: PHASE4
-
New Generation Drug Eluting Stent for In-stent Restenosis of Drug Eluting Stent( RESTENT-ISR Trial )
NCT01365572 ·Status: UNKNOWN ·Phase: PHASE4
-
Korean Nationwide Multicenter Pooled Registry of Drug-Eluting Stents
NCT03507205 ·Status: COMPLETED
-
CONNECT DES Registrty
NCT04715594 ·Status: UNKNOWN
-
Evaluation of Effectiveness and Safety of XIENCE Sierra in Routine Clinical Practice
NCT03967158 ·Status: ACTIVE_NOT_RECRUITING
-
Comparison of Cilotax Stent and Everolimus -Eluting Stent With Diabetes Mellitus (ESSENCE-DM III)
NCT01515228 ·Status: COMPLETED ·Phase: PHASE4
-
Procedural Advantages of a Novel Drug-Eluting Coronary Stent
NCT02881216 ·Status: COMPLETED ·Phase: NA
-
Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-IV: (LONG-DES-IV)
NCT01186094 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Zotarolimus-Eluting Stent vs Sirolimus-Eluting Stent for Diabetic Patients
NCT01186107 ·Status: COMPLETED ·Phase: PHASE4
-
LONG-DES VI (Drug Eluting Stent for Long Lesions in Coronary Artery)
NCT01489761 ·Status: TERMINATED ·Phase: PHASE4
-
Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III (LONG-DES-III)
NCT01078038 ·Status: COMPLETED ·Phase: PHASE4
-
Anatomic Versus Physiologic Guidance for Complete Revascularization With DES Eluting in Patients With CAD
NCT05529459 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of ZotaRolimus-Eluting Coronary Stent System In Patients With Long Coronary Artery Disease
NCT04825886 ·Status: COMPLETED
-
Adhesiveness of Coronary Drug-Eluting Stents to the Delivery Balloon-Catheter: A Randomized Comparison
NCT00279006 ·Status: UNKNOWN ·Phase: NA
-
Drug-Coated Balloon in Patients With High Bleeding Risk
NCT05221931 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The DECISION-CTO Extended 10 Y Follow-up
NCT06908499 ·Status: NOT_YET_RECRUITING
-
Study on Absorbable Zinc Alloy Drug Eluting Coronary Stent System
NCT05477940 ·Status: UNKNOWN ·Phase: NA
-
DEB Versus 2nd Generation DES in Patients With In-Scaffold Restenosis of Bioresorbable Vascular Scaffold
NCT03074305 ·Status: WITHDRAWN ·Phase: NA
-
Registry to Evaluate the Efficacy of Zotarolimus-Eluting Stent
NCT00960908 ·Status: UNKNOWN
-
Comparison of Everolimus-Eluting Stent vs Sirolimus-Eluting Stent in Patients With DIABETES Mellitus
NCT00997763 ·Status: COMPLETED ·Phase: PHASE4
-
Drug-eluting Stents vs. Drug-coated Balloon for Preventing Recurrent In-stent Restenosis
NCT01967199 ·Status: TERMINATED ·Phase: PHASE4
-
Retrospective Study of the Impact of Drug Eluting Stents
NCT00487604 ·Status: UNKNOWN
-
Focal In-stent Restenosis After Drug-Eluting Stent
NCT00485004 ·Status: COMPLETED ·Phase: PHASE4